Complaince Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st March, 2026 as attached.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ishita Drugs & Industries Ltd has submitted a routine compliance certificate from their Registrar and Transfer Agent (RTA), Bigshare Services Pvt Ltd, as mandated under SEBI regulations. The certificate confirms that no securities were received from depository participants for dematerialization during the quarter ending March 31, 2026 (January to March 2026). Since there were no dematerialization requests, no share certificates were mutilated, cancelled, or had depositories' names substituted in the register of members. This is a standard quarterly regulatory filing required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.
This is a routine regulatory compliance filing with no impact on shareholders or stock price. It simply confirms normal share registry operations with zero dematerialization activity during the quarter.